seed
Stage
2020
Founded
2
Investors
About
Aignosis is a medical device company developing AI-powered solutions for the early and accurate diagnosis of neurological disorders. Their initial product focuses on improving the assessment of Multiple Sclerosis progression.
Explore Aignosis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.